Laurus Labs Limited
LAURUSLABS
Kedudukan dalam Saham
#1737
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Harga Saham
$22.83
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$12.34B
Perubahan (1 hari)
0.51%
Perubahan (1 tahun)
117.95%
Negara
IN
Perdagangan Laurus Labs Limited (LAURUSLABS)
Kategori
Healthcare
Bilangan saham terbitan bagi Laurus Labs Limited (LAURUSLABS)
Bilangan saham terbitan setakat June 2026: 539.79M
Menurut laporan kewangan terkini dan harga saham Laurus Labs Limited, bilangan saham terbitan semasa ialah 539.79M. Pada akhir March 2024, syarikat mempunyai 540.57M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Laurus Labs Limited (LAURUSLABS) dari 2013 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2026 (TTM) | 539.79M | 0.03% |
| 2025 | 539.64M | -0.17% |
| 2024 | 540.57M | 0.16% |
| 2023 | 539.69M | 0.11% |
| 2022 | 539.10M | 0.19% |
| 2021 | 538.06M | 0.87% |
| 2020 | 533.42M | 0.13% |
| 2019 | 532.75M | 0.19% |
| 2018 | 531.76M | 16.15% |
| 2017 | 457.83M | -6.95% |
| 2016 | 492.04M | 10.95% |
| 2015 | 443.48M | 0.00% |
| 2014 | 443.48M | 9.11% |
| 2013 | 406.44M | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 344.49% |
IN
|
